The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?

CNS Neuroscience & Therapeutics
Johann SellnerOlaf Stüve

Abstract

Recent studies support the notion that statins, widely prescribed cholesterol-lowering agents, may target key elements in the immunological cascade leading to inflammation and tissue damage in the pathogenesis of multiple sclerosis (MS). Compelling experimental and observational clinical studies highlighted the possibility that statins may also exert immunomodulatory synergy with approved MS drugs, resulting in several randomized clinical trials testing statins in combination with interferon-beta (IFN-β). Some data, however, suggest that this particular combination may not be clinically beneficial, and might actually have a negative effect on the disease course in some patients with MS. In this regard, a small North American trial indicated that atorvastatin administered in combination with IFN-β may increase disease activity in relapsing-remitting MS. Although other trials did not confirm this finding, the enthusiasm for studies with statins dwindled. This review aims to provide a comprehensive overview of the completed clinical trials and reports of the interim analyses evaluating the combination of IFN-β and statins in MS. Moreover, we try to address the evident question whether usage of this combination routinely requires c...Continue Reading

References

May 2, 2001·Nature Reviews. Molecular Cell Biology·T Taniguchi, A Takaoka
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeanne M SoosScott S Zamvil
Nov 14, 2002·Neuroscience Letters·Romesh StanislausInderjit Singh
Mar 12, 2003·The Journal of Experimental Medicine·Orhan AktasFrauke Zipp
Mar 28, 2003·American Heart Journal·Luther T Clark
Apr 18, 2003·Endothelium : Journal of Endothelial Cell Research·Gabriele Weitz-Schmidt
Jun 5, 2003·Annals of Neurology·Jieli ChenMichael Chopp
Jul 17, 2003·Journal of Neurology·Armando SenaM Graça Morais
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Narender NathInderjit Singh
Mar 20, 2004·Journal of Neurochemistry·Joachim G SchulzMatthias Endres
May 18, 2004·Lancet·Timothy VollmerInderjit Singh
Jun 16, 2004·Journal of Neuroscience Research·Ajaib Singh PaintliaInderjit Singh
Mar 29, 2005·Nature Neuroscience·Gesine SaherKlaus-Armin Nave
Apr 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sonia WaicziesFrauke Zipp
Aug 30, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ajaib S PaintliaInderjit Singh
Mar 18, 2006·The Journal of Clinical Investigation·Olaf StüveScott S Zamvil
Apr 28, 2006·Nature Reviews. Immunology·John GreenwoodScott S Zamvil
Jul 25, 2006·Journal of Neuroimmunology·Martin S WeberScott S Zamvil
May 12, 2007·Expert Review of Neurotherapeutics·Oliver Neuhaus, Hans-Peter Hartung
Aug 23, 2007·Nature Immunology·Henry F McFarland, Roland Martin
Dec 18, 2007·Drugs·Olaf StüveElliot M Frohman
Mar 18, 2008·Clinical and Experimental Immunology·J SellnerH P Mattle
Apr 1, 2008·Journal of Alzheimer's Disease : JAD·Amalia M DolgaUlrich L M Eisel
May 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin ZhangSilva Markovic-Plese
May 20, 2008·Immunologic Research·Xin Zhang, Silva Markovic-Plese
Jun 6, 2008·Neurochemistry International·Johann SellnerHeinrich P Mattle
Jun 25, 2008·Multiple Sclerosis : Clinical and Laboratory Research·J SellnerH P Mattle
Aug 30, 2008·Multiple Sclerosis : Clinical and Laboratory Research·Ra MarrieT Vollmer
Oct 29, 2008·Neurology·Myla D Goldman, Jeffrey A Cohen
Dec 17, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Steve KlopfleischWolfgang Brück
Mar 28, 2009·Journal of Neurology·Bernd C KieseierOlaf Stüve

❮ Previous
Next ❯

Citations

Apr 19, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Bianca Weinstock-GuttmanMurali Ramanathan
Oct 6, 2011·Journal of Neuroinflammation·Bianca Weinstock-GuttmanMurali Ramanathan
Mar 25, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Ulivieri, Cosima T Baldari
Nov 28, 2013·The International Journal of Neuroscience·Oliver FindlingJohann Sellner
Mar 6, 2016·Current Neurology and Neuroscience Reports·Benedikt KretzschmarMartin S Weber
Sep 14, 2012·Neurological Research·Yuval KarmonBianca Weinstock-Guttman
Aug 18, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Shilpa BhardwajDiana M Sobieraj

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.